anti-Polyoma Virus, Medium T Antigen antibody product blog
Tags: Antibody; Monoclonal Antibody; Polyoma Virus, Medium T Antigen; anti-Polyoma Virus, Medium T Antigen antibody;
The Polyoma Virus, Medium T Antigen n/a (Catalog #MBS603687) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The Polyoma Virus, Medium T Antigen (Polyomavirus Medium T Antigen, MT-AG, Middle An Antigen, MPyVgp2, Polyoma Virus Middle T Antigen, Polyomavirus Middle T Antigen) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s Polyoma Virus, Medium T Antigen can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunoprecipitation (IP), Immunofluorescence (IF).Suitable for use in Western Blot, Immunoprecipitation and Immunofluorescence. Researchers should empirically determine the suitability of the Polyoma Virus, Medium T Antigen n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Polyoma Virus, Medium T Antigen binds medium T antigen only and allows isolation of viral T antigens.
Immunogen: Synthetic peptide corresponding to the N terminal of Polyoma Virus, Medium T Antigen. Cellular Localization: Cytoplasmic location in cells infected with virus. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Polyoma Virus, Medium T Antigen are readily searchable from our website. Different antibodies against the same target such as Polyoma Virus, Medium T Antigen may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.